Case Report {#sec1-1}
===========

Clinical history {#sec2-1}
----------------

A 87-year old male presented to his family physician with a two week history of a skin lesion on his right anterior chest. On physical exam, particular emphasis was on head and neck assessment. On inspection of the head and neck there were no gross abnormalities including asymmetry, swelling, discoloration and or trauma. Major lymph nodes were identified symmetrically on both sides of the neck. All cranial nerves were tested to be within normal limits of functioning. The oropharynx was visualized to be without obvious lesions or deformity. On examination of the chest, a solitary 2.5 cm light brown ulcerated polyploid growth was seen. The surrounding epidermis was without erythema or hemorrhage. No telangiectatic vessels were seen grossly.

During the course of getting worked up for possible metastatic disease, a head/neck CT was performed. The results of this scan were essentially normal anatomy without any obvious lesion present (including nasopharynx). The lesion was removed with the clinical diagnosis of an epidermal carcinoma. Since the excision the patient was been in good medical health with no recurrent tumor or distant metastatic spread.

Microscopic examination {#sec2-2}
-----------------------

Histopathology on low power showed an unremarkable epidermal surface, with no ulceration or dysplastic changes ([Figure 1A](#fig001){ref-type="fig"}). The architecture of the lesion was that of scattered nests of tumor cells with diffuse lymphocytic infiltrate between epithelial nests. On higher power examination ([Figure 1B](#fig001){ref-type="fig"}), the biphasic nature of the lesion became more apparent. The tumor cells were mainly polygonal in shape with an eosinophilic cytoplasm, containing vesicular nuclei, prominent atypia, numerous mitosis, diffuse lymphoplasmacytic infiltrate surrounding the epithelial nests and an infiltrating tumor margin. Histological features that may suggest a more aggressive form of LELCS such as involved surgical margins, lymphvascular and or perineural invasion were all negative on examination.[@ref1]

Immunohistochemical (IHC) studies showed that the tumor cells were diffusely positively for epithelial differentiation (AE1/AE3 and EMA) and more specifically squamous cell involvement with CK5/6 ([Figure 1C](#fig001){ref-type="fig"}). Lymphoid cell markers (LCA, CD3 & CD20) were also helpful in identifying reactive nature of the surrounding lymphoid cells, while remaining negative for the epithelial tumor nests. Melanoma markers (S-100 & HMB45) and neuroendocrine markers (Chromogranin, Synaptophysin & CD56) were also negative for tumor cell involvement. The tumor cells also reacted negativity with Epstein-Barr virus (EBV) ([Figure 1D](#fig001){ref-type="fig"}). The full immunohistochemistry panel is summarized in [Table 1](#table001){ref-type="table"}.

The clinical history of unremarkable head and neck examination with supporting radiology correlate the theory that this lesion was a different entity from the nasopharyngeal counterpart. Therefore hematoxylin and eosin (H&E), immunohistochemistry (IHC) and clinical history were all consistent with the diagnosis of lymphoepithelioma -- like carcinoma of the skin (LELCS).

Discussion {#sec1-2}
==========

LELCS is defined as a rare and poorly differentiated variant of squamous cell carcinoma, with prominent reactive inflammatory infiltrate mimicking undifferentiated nasopharyngeal carcinoma (lymphoepthelioma). Historically, majority of cases of lymphoepithelioma were found to have a relationship with Epstein-Barr virus (EBV), while LELCS neoplasms were not.^[@ref2],[@ref3]^ A literature review revealed only one documented case of EBV-positive LELCS.[@ref4] This distinction is what often differentiates LELCS from lymphoeptheliomatous tumors of the nasopharynx.

Clinically both tumors most often present in the head and neck region as an enlarging erythematous nodular lesion, however, there have been reports from numerous other sites with similar tumors including the gastrointestinal tract, genitourinary tract and reproductive organs.[@ref5; @ref6; @ref7] LELCS is a slow indolent growing epithelial neoplasm with moderate tendency to metastasize.[@ref8] The size of the lesion varies among locations and reports, however the majority average between 2 to 3 cm in diameter. These tumors affect mainly elderly patients with equal distribution among males and females.

The differential diagnosis with LELCS is rather extensive including metastatic disease from nasopharyngeal carcinoma, lymphoma, poorly differentiated inflamed carcinoma, Merkel cell carcinoma and melanoma. Lymphoepithelioma is histologically identical to LELCS, and therefore needs to be ruled out clinically with imaging and history. This often includes CT scan of the chest with nasopharyngeal swabs. As previously stated the skin tumors have only been reactive for EBV-encoded RNA in one documented case.^[@ref4],[@ref9; @ref10; @ref11]^ Poorly differentiated inflamed carcinoma's, are often in the differential diagnosis due to the similar histological appearance as well. Poorly differentiated inflamed carcinomas in contrast have areas of well differentiated carcinoma or overlying carcinoma *in situ*. With dense lymphoid infiltrate, lymphoma is often considered, however the latter does not present with an epithelial component. In contrast to this case, Merkel cell carcinoma would react positivity with neuroendocrine markers. Melanoma can be excluded by careful histological examination that lack residual melanocytes, and overlying melanoma *in situ* component. As well immunohistochemistry should show negativity for melanocytic markers including S100, Melan-A and HMB-45.

The microscopic examination has a dermal infiltrate of predominately lymphoid cells associated with enlarged, atypical epithelioid cells. The epithelioid cells may form small nests or clusters of tumor cells often being difficult to discern due to the heavy lymphoid infiltrate. On high magnification examination, the atypical cells show enlarged nuclei and prominent nucleoli, with vesicular chromatin. In some cases focal overlying SCC *in situ* may be identified.

Immunohistochemical profile is a critical aspect in the diagnosis of LELCS. The atypical epithelioid cells should be positive for cytokeratins, especially high molecular weight cytokeratins such as CK5/6 and CK903.12 Other positive markers include p63 and EMA (over 90% accuracy). Lymphoid markers, particularly T-cell markers, will highlight the dense background of lymphoid infiltrate.[@ref13] The other markers generally used are relevant to the individual clinical history and presentation of the patient.

LELCS is treated similarly to invasive SCC with wide local surgical excision being the standard of care with radiation reserved for tumor reoccurrence or lymph node involvement.^[@ref1],14^ Currently, LELCS is classified as a variant of SCC with intermediate malignant potential. Few cases of recurrence are reported, however, most patients enjoyed long term survival with no recurrence.

The association between lymphoepithelioma and EBV has been documented in several studies.[@ref9; @ref10; @ref11] There have been a total of 25 reports that correlate the theory that EBV involvement supports the diagnosis of lymphoepithelioma. EBV associated lymphoepithelioma has been documented in lungs, thymus, salivary glands and gastrointestinal tract. However, LELCS have been documented to have much higher variability in terms of anatomical location.

Conclusions {#sec1-3}
===========

In conclusion, LELCS is a rare poorly differentiated variant of SCC with distinct pathogenesis differing from undifferentiated nasopharyngeal carcinoma. Standard morphology is often misleading and needs to be correlated with ancillary studies and full clinical history. The clinical work up includes head and body CT scans and extensive ENT examination to rule out metastatic disease. Despite similar histological presentations, the two diseases are treated with very different approaches. Lymphoepithelioma is treated with supervoltage radiotherapy, while LELCS is treated with surgical excision for non-aggressive forms. Additionally, this case highlights the rationalization that making the distinction between lymphoepithelioma and LELCS is crucial to patient care.

![A) Hematoxylin & Eosin, 40×; B) Hematoxylin & Eosin, 200×; C) CK5/6, 100×; D) Epstein-Barr Virus, 100×.](rt-2013-3-e47-g001){#fig001}

###### 

Immunohistochemistry panel.

  Stain            Result
  ---------------- --------
  AE1/AE3          \+
  CAM 5.2          \+
  CK5/6            \+
  EMA              \+
  HMWCK (34BE12)   \+
  CK7              \+
  CK18             \+
  CK19             \+
  CK20             \*
  CD3              \*
  LCA              \*
  CD20             \-
  CD56             \-
  Chromogranin     \-
  Synaptophysin    \-
  S100             \-
  HMB45            \-
  EBV              \-

\+ represents positive for tumor cells; \* represents positive for lymphoid cells, negative for tumor cells; - represents negative for tumor cells.

[^1]: Conference presentation: case report was presented at McMaster University Resident Research Day, May 2013 (Hamilton, Ontario).
